Postoperative dendritic cell vaccine plus activated T-cell transfer improves the survival of patients with invasive hepatocellular carcinoma

The recurrence rate after surgery in patients with hepatocellular carcinoma (HCC) is very high, while prognosis is quite poor. However, there is no standard treatment to prevent recurrence of HCC after a curative operation. In this study, we investigated the clinical utilization of an autologous tum...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Hum Vaccin Immunother
Главные авторы: Shimizu, Koichi, Kotera, Yoshihito, Aruga, Atsushi, Takeshita, Nobuhiro, Katagiri, Satoshi, Ariizumi, Shun-ichi, Takahashi, Yutaka, Yoshitoshi, Kenji, Takasaki, Ken, Yamamoto, Masakazu
Формат: Artigo
Язык:Inglês
Опубликовано: Taylor & Francis 2014
Предметы:
Research Paper
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4896569/
https://ncbi.nlm.nih.gov/pubmed/24419174
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.27678
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы